The data in this study suggested that RBM15 could stabilize SRSF1 mRNA via the m6A reader YTHDF3 and that increased SRSF1 enhanced the ATP7B alternative splicing to inhibit cuproptosis in NSCLC. Here, YTHDF3 is linked to non-small cell lung carcinoma.